GlassScriptPhysician profile
Gurpreet Kaur
NPI 1881377729
$779.81
in general payments reported to CMS, 2019-2025
12 companies · $161 in 2025
The $161 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
See the full distribution for Gerontology (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $127 · 2024: $492 · 2025: $161.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $780.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $779.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $162.48 | 2023-2024 | |
| Alexion Pharmaceuticals, INC. | $128.52 | 2025 | Ultomiris |
| Ardelyx, INC. | $125.00 | 2024 | Ibsrela |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $123.15 | 2024 | Xifaxan, Plenvu |
| Takeda Pharmaceuticals U.S.A., INC. | $91.68 | 2023-2024 | Entyvio, Gattex |
| Madrigal Pharmaceuticals | $32.09 | 2025 | Rezdiffra |
| Regeneron Healthcare Solutions, INC. | $23.80 | 2024 | Dupixent |
| Celgene Corporation | $23.53 | 2023 | Zeposia |
| Lilly USA, LLC | $23.16 | 2024 | Omvoh |
| Aimmune Therapeutics, INC. | $17.68 | 2024 | |
| Fresenius Kabi USA, LLC | $15.58 | 2023 | Idacio |
| Abbvie INC. | $13.14 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gurpreet Kaur listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.